Use of prophylactic antifungals in the immunocompromised host.

@article{Ship2007UseOP,
  title={Use of prophylactic antifungals in the immunocompromised host.},
  author={Jonathan A. Ship and A Vissink and Stephen J Challacombe},
  journal={Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics},
  year={2007},
  volume={103 Suppl},
  pages={S6.e1-14}
}
Oral candidiasis is a significant infection in patients being treated with chemotherapy and radiotherapy for cancer, and in patients who are immunocompromised because of HIV infection and AIDS. Candida albicans is the most common fungal pathogen and has developed an extensive array of putative virulent mechanisms that allows successful colonization and infection of the host under suitable predisposing conditions. The purpose of this review of the literature was to assess the effectiveness of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…